AzTrials
AzTrials

Percutaneous Coronary Intervention (PCI)TIRENCT07572422

Use of Various Types of Introducers in Conventional Radial Access

A study testing catheterization of the radial artery using an classic introducer, catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coating and catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coating in people with Percutaneous Coronary Intervention (PCI) and Radial Artery Occlusion, run by Pirogov Russian National Research Medical University at 2 sites in Russia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this intervention study is to compare different types of radial introducers used in traditional radial access in terms of the incidence of complications. The main questions it aims to answer are: 1. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
catheterization of the radial artery using an classic introducer, catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coating and catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coating
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,307 participants
Where
2 sitesRussia
Study dates
28 Jan 2019to 19 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • clear pulsation of the right radial artery
  • indications for percutaneous coronary intervention

Who cannot join

  • previous unsuccessful radial artery catheterization
  • concomitant pathology limiting patient survival
  • disorders of the blood coagulation system (hemophilia, thrombocytopathy, etc.)
  • previous coronary artery bypass grafting
  • occlusion of the right radial artery

Trial locations and contacts

2 sites in 1 country.

Russia2 sites
  • E.I. Korolev Kostroma Regional Clinical Hospital

    Kostroma, Kostroma Oblast, 156013

  • Central Clinical Hospital of St. Alexy Metropolitan of Moscow of the Moscow Patriarchate of the Russian Orthodox Church

    Moscow, Moscow, 119071

Other trials in Russia

About this study

The purpose of this intervention study is to compare different types of radial introducers used in traditional radial access in terms of the incidence of complications.

The main questions it aims to answer are:

Read more
  1. Does a smaller outer diameter of the introducer reduce the risk of complications associated with radial access?
  2. Does the presence of an outer hydrophilic coating on the introducer reduce the risk of complications associated with radial access?
  3. Does the use of an introducer with a smaller outer diameter and an outer hydrophilic coating reduce the risk of complications associated with radial access? The researchers will compare the number of complications associated with radial access when using conventional diameter, uncoated radial introducers, conventional diameter introducers with an outer hydrophilic coating, or reduced outer diameter introducers with an outer hydrophilic coating.

During the scheduled revascularization procedure, the participants will undergo radial artery catheterization using one of the types of introducers. Complications from the radiation access will be recorded by doctors within 72 hours after the intervention.

Read the detailed description

Objective: to compare different types of radial introducers used in conventional radial access by the frequency of complications.

Scientific hypotheses:

  1. The risk of acute radial artery occlusion depends on the outer diameter of the introducer.
  2. The risk of acute radial artery occlusion depends on the presence of an outer hydrophilic coating on the introducer.
  3. The risk of persistent radial artery spasm depends on the presence of an outer hydrophilic coating on the introducer.
  4. The risk of persistent radial artery spasm depends on the outer diameter of the introducer.

Patients were enrolled by endovascular specialists with experience of at least 250 radial-access procedures per year.

Inclusion criteria: clear pulsation of the right radial artery, indications for percutaneous coronary intervention.

Exclusion criteria: previous unsuccessful radial artery catheterization; concomitant pathology limiting patient survival; disorders of the blood coagulation system (hemophilia, thrombocytopathy, etc.); previous coronary artery bypass grafting; occlusion of the right radial artery.

The required sample size was calculated using the method of M. Bland for a high-precision study. The required significance level (α) was 0.001 and the statistical power was 95%. The expected rate of radial artery occlusion in the Rad, Rad polymer, and Rad slender groups was assumed to be 12%, 8%, and 8%, respectively. Under these conditions, the calculated sample size was 2723 patients. The planned loss during the study was 20%. Thus, the minimum sample size was 3268 patients.

The study had an experimental design and complied with the CONSORT protocol. A simple randomization method using a random-number generator was chosen. The type of randomization was permuted block randomization. The total block size was 3000, and the allocation ratio between the groups was 1:1:0.7.

Puncture of the right radial artery was performed after local anesthesia with a 2% lidocaine solution. The radial artery was punctured at the typical site using the puncture needle included in the introducer set, with only the anterior wall being punctured. The type of introducer was selected by randomization using a random-number method, and depending on this assignment the patient was allocated to one of the groups.

All patients underwent percutaneous coronary angioplasty with coronary artery stenting via the right radial artery. The radial artery catheterization technique did not differ between groups. The type of introducer was selected by randomization using a random-number method, and depending on this assignment the patient was allocated to one of the groups. In the Rad group , introducers without a hydrophilic coating were used; in the Rad polymer group , introducers with a hydrophilic coating were used; and in the Rad slender group , thin-walled introducers with a hydrophilic coating were used. The access site was examined within 3 hours after the intervention and then, in the absence of complaints, again at bandage removal. After bandage removal, patients underwent ultrasound examination to confirm radial artery patency. Complications from the radiation access will be recorded by doctors within 72 hours after the intervention.

Being tested
catheterization of the radial artery using an classic introducer, catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coating, catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coating
Keywords
radial access, types of radial introducers, Radial Artery Spasm, Percutaneous Coronary Intervention (PCI), Radial artery occlusion, Randomized study
Medical subject headings
Arterial Occlusive Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • catheterization of the radial artery using an classic introducerProcedure or surgery

    The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

    An introducer with a standard outer diameter and no external hydrophilic coating was inserted.

    5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage.

    The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery.

    Complications were recorded within 3 days after the intervention.

  • catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coatingProcedure or surgery

    Description: The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

    An introducer with a standard outer diameter and an outer hydrophilic coating was using.

    5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage. The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery. Complications were recorded within 3 days after the intervention.

  • catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coatingProcedure or surgery

    Description: The right radial artery was punctured under local anesthesia with a 2% lidocaine solution. The radial artery was punctured at a typical location using a puncture needle included in the catheterization kit, puncturing only the anterior wall.

    An introducer with a reduced outer diameter and an outer hydrophilic coating was using.

    5,000 IU of heparin in saline solution was injected into the catheterized artery. All injected solutions, including radiocontrast agents, had a temperature of 36.5-36.7 °C. Hemostasis was achieved by applying a pressure bandage. The access site was examined 3 hours after the intervention, and then, if there were no complaints, it was examined again when the bandage was removed. After the bandage was removed, patients underwent an ultrasound examination to confirm the patency of the radial artery. Complications were recorded within 3 days after the intervention.

Study groups in NCT07572422
Study groupRoleWhat they receive
Rad classicActive comparatorIntroducer with a standard outer diameter and no external hydrophilic coating
Receives: Procedure: catheterization of the radial artery using an classic introducer
Rad polymerExperimentalIntroducer with a standard outer diameter and an outer hydrophilic coating
Receives: Procedure: catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coating
Rad slenderExperimentalIntroducer with a reduced outer diameter and an outer hydrophilic coating
Receives: Procedure: catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coating

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acute radial artery occlusion after catheterization

    Acute radial artery occlusion was confirmed by ultrasound examination

    Measured: Within 72 hours after radial artery catheterization

  2. Radial artery perforation

    Angiography-confirmed perforation of the radial artery

    Measured: Perioperative/Periprocedural

  3. Radial artery false aneurysm

    A false aneurysm of the radial artery was confirmed by ultrasound examination

    Measured: Within 72 hours after radial artery catheterization

  4. Hematoma by classification EASY Grade II

    Hematoma by classification EASY Grade II was confirmed by ultrasound examination

    Measured: Within 72 hours after radial artery catheterization

  5. Persistent radial artery spasm

    Persistent radial artery spasm confirmed by angiography

    Measured: Perioperative/Periprocedural

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2026
  2. Study start28 Jan 2019
  3. Primary completion16 Dec 2025
  4. Study completion19 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
3,307 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07572422
Sponsor's protocol ID
260/1
Acronym
TIRE
Status last verified
May 2026
First submitted
22 Apr 2026
Last updated
13 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all personal data underlying the publication results

Questions about this trial

What is this clinical trial studying?

A study testing catheterization of the radial artery using an classic introducer, catheterization of the radial artery using an introducer with a standard outer diameter and an outer hydrophilic coating and catheterization of the radial artery using an introducer with a reduced outer diameter and an outer hydrophilic coating in people with Percutaneous Coronary Intervention (PCI) and Radial Artery Occlusion, run by Pirogov Russian National Research Medical University at 2 sites in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acute radial artery occlusion after catheterization (time frame: Within 72 hours after radial artery catheterization). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in